AMBER DELASALLE: Open Payments
NPI 1538816616 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 67 payments from 14 companies in 2025. Trend: 2023 $631 · 2024 $823 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 15 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $245 |
| Axsome Therapeutics, Inc. | 6 | $138 |
| ABBVIE INC. | 6 | $129 |
| Supernus Pharmaceuticals, Inc. | 6 | $89 |
| Alkermes, Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Bausch Health US, LLC | 1 | $29 |
Products named: REXULTI, CAPLYTA, Auvelity, VRAYLAR, Qelbree, ARISTADA, TRINTELLIX, SPRAVATO.
Industry payments across LA — which companies pay providers there.
